Investor Relations
Partnerships are integral to Harbour BioMed's strategy to build a fully integrated biopharmaceutical company.
-
Apr 02, 2025
2024 Annual Results Online Conference
-
Aug 28, 2024
2024 Interim Results Online Conference
-
Mar 28, 2024
2023 Annual Results Online Conference
-
Dec 15, 2023
HBM 9033 Out-license to Pfizer
-
Aug 29, 2023
2023 Interim Results Online Conference
Copyright © 2025 Harbour BioMed. All Rights Reserved
沪公网安备31011502401396号
沪ICP备19015946号-1